-
Mashup Score: 0How AI Will Transform Health Equity In Clinical Trials In 2025 - 4 month(s) ago
Click Therapeutics’ CMO/CSO Shaheen Lakhan, MD, Ph.D., FAAN explains how the shift toward AI is the first step in addressing diversity in clinical trials.
Source: www.clinicalleader.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1PI Insights From A Heart Failure Trial: Part 2 - 5 month(s) ago
This is part 2 of Dan Schell’s interview with Jennifer Cowger, MD, the co-principal investigator of the Abbott TEAM-HF clinical trial. Here, she elaborates more on some of her tasks specific to this heart failure trial.
Source: www.clinicalleader.comCategories: General Medicine News, CardiologistsTweet-
PI Insights From A Heart Failure Trial: Part 2 https://t.co/CEdT7UBbK7
-
-
Mashup Score: 0What Can Digital Patient Twins Do For Clinical Research? - 1 year(s) ago
Digital patient twins have the potential to vastly improve our current healthcare systems by offering personalized therapeutics, enhanced health monitoring, and streamlined pharmaceutical manufacturing, including clinical trials.
Source: www.clinicalleader.comCategories: General Medicine News, Future of MedicineTweet-
What Can Digital Patient Twins Do For Clinical Research? https://t.co/735QbOi1e2 https://t.co/KjVEKxr6da
-
-
Mashup Score: 04 Questions About A Digital Therapeutic Clinical Trial - 1 year(s) ago
Tim Peters-Strickland, SVP, clinical development & medical affairs at Click Therapeutics, explains some of the details that went into the recently FDA-approved Rejoyn digital therapeutic, which was a joint collaboration between Otsuka and Click.
Source: www.clinicalleader.comCategories: General Medicine News, Future of MedicineTweet-
4 Questions About A Digital Therapeutic Clinical Trial https://t.co/sGypwI7nd6
-
-
Mashup Score: 5Addressing Underrepresentation In Cancer Trials: A Q&A With Stand Up To Cancer & Triage Cancer - 1 year(s) ago
Clinical Leader heard from both sides of the collaboration — SU2C researcher Dr. Chanita Hughes-Halbert, Ph.D., and grant recipient Triage Cancer co-founder and COO Monica Fawzy Bryant, Esq. — to explore each’s efforts to together bring health equity to those diagnosed with cancer.
Source: www.clinicalleader.comCategories: General Medicine News, Onc News and JournalsTweet-
#StandUpToCancer’s Diversity in Early Development Clinical Trials Program, supported by @JNJNews, is hard at work. Recently, a SU2C scientist & a grantee spoke to @ClinicalLeader1 about their recent progress to improve diversity in cancer clinical trials: https://t.co/w65i6jfOAL.
-
-
Mashup Score: 2
Human-centric design should be the starting point for identifying the core issues that drive innovation, experimentation, and finding solutions to unlock the full potential of digital health. Amy West, head of U.S. digital transformation & innovation at Novo Nordisk, explains.
Source: www.clinicalleader.comCategories: General Medicine News, Future of MedicineTweet-
Putting Patients First: Human-Centric Approaches In Digital Healthcare https://t.co/7bcrll345x https://t.co/WcMp5AOosq
-
-
Mashup Score: 0
The clinical trials industry is compelled to embrace digital transformation in its approach to patient recruitment and engagement, study design protocols, and overall trial management. But what’s the crucial component to ensure its success? Global standards that help cultivate trust.
Source: www.clinicalleader.comCategories: Future of Medicine, Latest HeadlinesTweet-
Trusting #DigitalHealth Technologies: Why Global Standards Are A Must https://t.co/ZsEN6oSBoP https://t.co/BakybIfHAS
-
-
Mashup Score: 2Should We Pay Patients In Clinical Trials For Their Time? - 3 year(s) ago
Many countries don’t reimburse clinical trial patients for their time and inconvenience. Is it ethical to pay them or not? This article looks at the perspectives of some of the major regulatory authorities. Can we find common ground? What actions can we take as members of industry?
Source: www.clinicalleader.comCategories: Future of Medicine, Latest HeadlinesTweet-
In clinical trials, everyone makes money except the patients. https://t.co/xgMc419MNS #pharma #clinicaltrials #digitalhealth
-
-
Mashup Score: 53 Strategies To Lead Clinical Research With Moral Integrity - 3 year(s) ago
In clinical research, perhaps our oldest code we live by is the Hippocratic oath. Our industry is more complicated today than ever before, so how can we remain loyal to our shared code while also supporting the innovative solutions and approaches of the modern world?
Source: www.clinicalleader.comCategories: Hem/Oncs, Latest HeadlinesTweet-
3 Strategies To Lead #Clinical #Research With Moral Integrity “While data integrity is of utmost importance in clinical research, moral integrity is of greater importance.” —Ravi Madan, MD, senior clinician, @theNCI @NCIResearchCtr https://t.co/dDnjlcrcwU
-
-
Mashup Score: 1Walgreens Is Ready To Re-Envision Recruitment, DCTs, And RWE - 3 year(s) ago
Since becoming CEO of Walgreens Boots Alliance (WBA) in March 2021, Rosalind Brewer has been focused on healthcare and what the company could do to help its patients. WBA refers to the integrated healthcare, pharmacy, and retail store that currently serves millions of customers and patients every day. This past June, the company launched its clinical trial…
Source: www.clinicalleader.comCategories: Latest Headlines, Rare DiseaseTweet-
RT @ABatemanHouse: Walgreens Is Ready To Re-Envision #ClinicalTrial Recruitment, DCTs, And RWE https://t.co/xAlVRBts3h cc @HayleyBelli
-
How #AI Will Transform #HealthEquity In #ClinicalTrials In 2025 https://t.co/8tu0VGBOUl